Events & Conferences

October, 2020 & October, 2021 – Marlou Bierlaagh, HIT-CF’s study coordinator, presented the primary screening results with the PTI and Eloxx drugs during respectively the 2020 and 2021 edition of the North American Cystic Fibrosis Conference. Click the images to enlarge.

October, 2020 – Kors van der Ent, HIT-CF’s principal investigator, had the opportunity to present an overview of the HIT-CF project during the virtual North American Cystic Fibrosis Conference. Watch his talk to get some interesting updates on the project.

January, 2020 – Proteostasis Therapeutics Inc. presented a poster on behalf of the HIT-CF Europe consortium at the Tissue Organoids as Models of Host Physiology and Pathophysiology of Disease symposium: Intestinal Organoid Models as a Path for Personalized Therapy Development in Cystic Fibrosis: